197 related articles for article (PubMed ID: 19903814)
1. Farnesyl pyrophosphate inhibits epithelialization and wound healing through the glucocorticoid receptor.
Vukelic S; Stojadinovic O; Pastar I; Vouthounis C; Krzyzanowska A; Das S; Samuels HH; Tomic-Canic M
J Biol Chem; 2010 Jan; 285(3):1980-8. PubMed ID: 19903814
[TBL] [Abstract][Full Text] [Related]
2. Skin Metabolite, Farnesyl Pyrophosphate, Regulates Epidermal Response to Inflammation, Oxidative Stress, and Migration.
Pastar I; Stojadinovic O; Sawaya AP; Stone RC; Lindley LE; Ojeh N; Vukelic S; Samuels HH; Tomic-Canic M
J Cell Physiol; 2016 Nov; 231(11):2452-63. PubMed ID: 26916741
[TBL] [Abstract][Full Text] [Related]
3. Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation.
Weivoda MM; Hohl RJ
Endocrinology; 2011 Aug; 152(8):3113-22. PubMed ID: 21586555
[TBL] [Abstract][Full Text] [Related]
4. Topical mevastatin promotes wound healing by inhibiting the transcription factor c-Myc via the glucocorticoid receptor and the long non-coding RNA Gas5.
Sawaya AP; Pastar I; Stojadinovic O; Lazovic S; Davis SC; Gil J; Kirsner RS; Tomic-Canic M
J Biol Chem; 2018 Jan; 293(4):1439-1449. PubMed ID: 29158265
[TBL] [Abstract][Full Text] [Related]
5. Farnesyl pyrophosphate regulates adipocyte functions as an endogenous PPARγ agonist.
Goto T; Nagai H; Egawa K; Kim YI; Kato S; Taimatsu A; Sakamoto T; Ebisu S; Hohsaka T; Miyagawa H; Murakami S; Takahashi N; Kawada T
Biochem J; 2011 Aug; 438(1):111-9. PubMed ID: 21605082
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mammalian squalene synthetase activity by zaragozic acid A is a result of competitive inhibition followed by mechanism-based irreversible inactivation.
Lindsey S; Harwood HJ
J Biol Chem; 1995 Apr; 270(16):9083-96. PubMed ID: 7721822
[TBL] [Abstract][Full Text] [Related]
7. Protein farnesyltransferase: measurement of enzymatic activity in 96-well format using TopCount microplate scintillation counting technology.
Harwood HJ
Anal Biochem; 1995 Apr; 226(2):268-78. PubMed ID: 7793628
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells.
Petras SF; Lindsey S; Harwood HJ
J Lipid Res; 1999 Jan; 40(1):24-38. PubMed ID: 9869647
[TBL] [Abstract][Full Text] [Related]
9. J-104,871, a novel farnesyltransferase inhibitor, blocks Ras farnesylation in vivo in a farnesyl pyrophosphate-competitive manner.
Yonemoto M; Satoh T; Arakawa H; Suzuki-Takahashi I; Monden Y; Kodera T; Tanaka K; Aoyama T; Iwasawa Y; Kamei T; Nishimura S; Tomimoto K
Mol Pharmacol; 1998 Jul; 54(1):1-7. PubMed ID: 9658183
[TBL] [Abstract][Full Text] [Related]
10. Statins inhibit blastocyst formation by preventing geranylgeranylation.
Alarcon VB; Marikawa Y
Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
[TBL] [Abstract][Full Text] [Related]
11. Low doses amino-bisphosphonates stimulate keratinocytes growth inactivating glucocorticoid receptor.
Renò F; Rizzi M; Invernizzi M; Migliario M; Cisari C
Eur J Pharmacol; 2013 Dec; 721(1-3):301-4. PubMed ID: 24063859
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of farnesyl diphosphate in tobacco BY-2 cells treated with squalestatin.
Hartmann MA; Wentzinger L; Hemmerlin A; Bach TJ
Biochem Soc Trans; 2000 Dec; 28(6):794-6. PubMed ID: 11171211
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level.
Peffley DM; Gayen AK
Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820
[TBL] [Abstract][Full Text] [Related]
14. A novel bisphosphonate inhibitor of squalene synthase combined with a statin or a nitrogenous bisphosphonate in vitro.
Wasko BM; Smits JP; Shull LW; Wiemer DF; Hohl RJ
J Lipid Res; 2011 Nov; 52(11):1957-64. PubMed ID: 21903868
[TBL] [Abstract][Full Text] [Related]
15. Squalene synthase inhibition alters metabolism of nonsterols in rat liver.
Keller RK
Biochim Biophys Acta; 1996 Oct; 1303(3):169-79. PubMed ID: 8908150
[TBL] [Abstract][Full Text] [Related]
16. Characterization of two distinct allyl pyrophosphatase activities from rat liver microsomes.
Bansal VS; Vaidya S
Arch Biochem Biophys; 1994 Dec; 315(2):393-9. PubMed ID: 7986083
[TBL] [Abstract][Full Text] [Related]
17. Farnesyl pyrophosphate is a novel transcriptional activator for a subset of nuclear hormone receptors.
Das S; Schapira M; Tomic-Canic M; Goyanka R; Cardozo T; Samuels HH
Mol Endocrinol; 2007 Nov; 21(11):2672-86. PubMed ID: 17666588
[TBL] [Abstract][Full Text] [Related]
18. Role of Phosphatidic Acid Phosphatase Domain Containing 2 in Squalestatin 1-Mediated Activation of the Constitutive Androstane Receptor in Primary Cultured Rat Hepatocytes.
Pant A; Kocarek TA
Drug Metab Dispos; 2016 Mar; 44(3):352-5. PubMed ID: 26700959
[TBL] [Abstract][Full Text] [Related]
19. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.
Vaidya S; Bostedor R; Kurtz MM; Bergstrom JD; Bansal VS
Arch Biochem Biophys; 1998 Jul; 355(1):84-92. PubMed ID: 9647670
[TBL] [Abstract][Full Text] [Related]
20. Farnesyl pyrophosphate is a novel pain-producing molecule via specific activation of TRPV3.
Bang S; Yoo S; Yang TJ; Cho H; Hwang SW
J Biol Chem; 2010 Jun; 285(25):19362-71. PubMed ID: 20395302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
